In-situ Growth of Covalent Organic Framework on Stainless Steel Needles As Solid-Phase Microextraction Probe Coupled with Electrospray Ionization Mass Spectrometry for Rapid and Sensitive Determination of Tricyclic Antidepressants in Biosamples

Jiahao Yuan,Weini Huang,Wei Tong,Zihan Chen,Heming Li,Jiajing Chen,Zian Lin
DOI: https://doi.org/10.1016/j.chroma.2023.463955
IF: 4.601
2023-01-01
Journal of Chromatography A
Abstract:Tricyclic antidepressants (TCAs) including amitriptyline (AT), doxepin (DOX) and nortriptyline (NT) are the first-line drugs for the clinical treatment of depression; however, monitoring TCA concentrations in biological fluids and tissues is necessary to improve therapeutic effect and determine the cause of death in patients. It is of great significance to develop a rapid and sensitive method for real-time monitoring of TCAs in various biosamples. In this work, we fabricated a novel covalent organic framework (COF) based solid-phase microextraction (SPME) probe by an in-situ step-by-step strategy, which was obtained by se-quentially modifying 1,3,5-tri (4-aminophenyl) benzene (TPB) and 2, 5-divinylbenzaldehyde (DVA) on the surface of polydopamine layer. The TPB-DVA-COF-SPME probe possessed high specific surface area (1244 m2 center dot g - 1 ), regular pores (3.23 nm), good hydrophobicity and stability, resulting in efficient enrichment for TCAs. Furthermore, the combination of TPB-DVA-COF-SPME probe and ambient electrospray ioniza-tion mass spectrometry system (ESI/MS) was firstly proposed for rapid and sensitive determination of TCAs in biosamples. As a result, the developed method exhibited low limits of detection (LODs) (0.1-0.5 mu g center dot L - 1 ), high enrichment factors (39-218), and low relative standard deviations (RSDs) for one probe (1.2-3.8%) and probe-to-probe (2.0-3.7%). Benefiting from these outstanding performance, TPB-DVA-COF-SPME probe was further successfully applied to biosamples (i.e., serum, liver, kidney, and brain) with excellent reusability, indicating the promising applicability of the TPB-DVA-COF-SPME-ESI/MS as a pow-erful tool for drug monitoring.(c) 2023 Elsevier B.V. All rights reserved.
What problem does this paper attempt to address?